The FDA Has Approved an Omicron Booster That Could Be Administered as Soon as Next Week Now that the FDA has approved the Omicron booster, the next step is for the CDC to review it. By Rachel Millman
Pfizer-BioNTech Begins Clinical Trial of Omicron-Targeted Vaccine It's still unclear whether an Omicron-specific vaccine is needed. By Sissi Cao
Omicron-Specific Vaccines Can Be Ready in 100 Days, Pfizer and Moderna CEOs Say "All the scientists I’ve talked to…are, like, 'this is not going to be good,'" said Moderna CEO Stéphane Bancel. By Sissi Cao
Moderna Vaccine Is Better Than Pfizer-BioNTech at Tackling Delta Variant, US Study Found By Sissi Cao